Corcept Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $412.3M
Liabilities Breakdown FY2019
Total Liabilities: $41.1M
Asset Breakdown
Total Assets: $412.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $31.3M | 7.6% |
| Accounts Receivable | $19.9M | 4.8% |
| Inventory | $5.4M | 1.3% |
| Property, Plant & Equipment | $1.1M | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $354.6M | 86.0% |
Liabilities Breakdown
Total Liabilities: $41.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.5M | 18.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $33.6M | 81.7% |